A case for combined ovarian and breast cancer prevention

Abstract Targeted prevention of ovarian cancer is hindered by the inaccessibility of ovarian tissue, lack of accepted biomarkers and low disease incidence. However, ovarian cancer has common risk factors and shared etiologies with breast cancer. Chemoprevention of ovarian cancer has been demonstrate...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Medical hypotheses 2012-10, Vol.79 (4), p.549-551
1. Verfasser:	Petroff, Brian K
Format:	Artikel
Sprache:	eng
Schlagworte:	Breast Neoplasms - prevention & control Clinical Trials as Topic Female Humans Internal Medicine Ovarian Neoplasms - prevention & control Risk Factors Risk Reduction Behavior
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Abstract Targeted prevention of ovarian cancer is hindered by the inaccessibility of ovarian tissue, lack of accepted biomarkers and low disease incidence. However, ovarian cancer has common risk factors and shared etiologies with breast cancer. Chemoprevention of ovarian cancer has been demonstrated incidentally during testing of novel breast cancer prevention drugs. Here it is hypothesized that the development of combined ovarian and breast cancer prevention strategies is a preferable strategy for ovarian cancer prevention.
ISSN:	0306-9877 1532-2777
DOI:	10.1016/j.mehy.2012.07.018